The Continuation of Trickle-Down Medicine: Soluble Suppression of Tumorigenicity-2 (sST2) in Pediatric Heart Failure [PDF]
Canadian Journal of Cardiology, 2019 openaire +2 more sources
Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis. [PDF]
Biosci Rep, 2019 Gu L, Li J.
europepmc +1 more source
Prognostic Utility of Soluble Suppression of Tumorigenicity 2 level as a Predictor of Clinical Outcomes in Incident Hemodialysis Patients. [PDF]
Int J Med Sci, 2018 Seo SM, Kim SH, Kim Y, Yoon HE, Shin SJ.
europepmc +1 more source
Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction. [PDF]
Med Sci Monit, 2018 Cui Y +5 more
europepmc +1 more source
European Journal of PediatricsThe purpose of this study was to evaluate the association between interleukin-33 (IL-33) and its receptor Soluble Suppression of Tumorigenicity-2 (sST2) levels and bacterial infections during febrile neutropenia (FN) in pediatric patients with acute lymphoblastic leukemia (ALL).
Neşe Yaralı +2 more
exaly +5 more sources
Related searches:
Plasma soluble suppression of tumorigenicity 2 and depression after acute ischemic stroke
European Journal of Neurology, 2021AbstractBackground and purposeSoluble suppression of tumorigenicity 2 (sST2) might be related to stroke and depression, but the association of sST2 with poststroke depression (PSD) is unclear. The study aimed to prospectively assess the association between plasma sST2 levels and PSD.MethodsA total of 635 acute ischemic stroke patients with sST2 ...
Yonghong Zhang, Sifan Qian, Aili Wang
exaly +3 more sources
Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome* [PDF]
Critical Care Medicine, 2016 ObjectivesSoluble suppression of tumorigenicity-2 and interleukin-6 concentrations have been associated with the inflammatory cascade of acute respiratory distress syndrome.
R Scott Harris +2 more
exaly +2 more sources
Poststroke depression and soluble suppression of tumorigenicity 2
European Journal of Neurology, 2021Recently, we have read the original article written by Yaling Lu et al1 , which was published in European Journal of Neurology [1]. The authors enrolled 635 acute ischemic stroke patients with soluble suppression of tumorigenicity 2 (sST2) measurements from the China Antihypertensive Trial in Acute Ischemic Stroke, one multicenter randomized clinical ...
Meidi Peng, Yachi Gong, Hongtao Huang
openaire +2 more sources
Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome [PDF]
Critical Care Medicine, 2013 ObjectivesSoluble suppression of tumorigenicity-2 is a biomarker of myocardial strain and inflammation. The characteristics of acute respiratory distress syndrome include inflammation and cardiovascular dysfunction.
R Scott Harris, James Januzzi
exaly +2 more sources
<b><i>Introduction:</i></b> Cardiovascular events (CVE) remain the leading cause of mortality in hemodialysis (HD) patients. The ability to assess the risk of short-term CVE is of great importance. Soluble suppression of tumorogenicity-2 (sST2) is a novel biomarker that better stratifies risk of CVE than troponins in patients ...
Mancianti N. +6 more
openaire +3 more sources